Literature DB >> 19491221

Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.

Antonio Ceriello1, Katherine Esposito, Michael Ihnat, Jessica Thorpe, Dario Giugliano.   

Abstract

OBJECTIVE: The objective of the study was to investigate the effect of different periods of hyperglycemia on the reversal of endothelial dysfunction by glucose normalization and antioxidant therapy. RESEARCH DESIGN AND METHODS: Ten healthy subjects and three subgroups of 10 type 1 diabetic subjects were enrolled as follows: 1) patients within 1 month of diagnosis; 2) patients between 4.5 and 5.2 yr from diagnosis and with glycosylated hemoglobin levels 7% or greater since diagnosis; 3) patients between 4.8 and 5.4 yr from diagnosis and with glycosylated hemoglobin levels greater than 7% since diagnosis. Each patient participated in three experiments: 1) 24-h insulin treatment, achieving a near normalization of glycemia, together with the addition of the antioxidant vitamin C during the last 12 h; 2) 24-h vitamin C treatment with insulin treatment for the last 12 h; and 3) treatment with both vitamin C and insulin for 24 h.
RESULTS: Endothelial function, as measured by flow-mediated vasodilation of the brachial artery and levels of nitrotyrosine, an oxidative stress marker, were normalized by each treatment in subgroups 1 and 2. In the third subgroup, neither glucose normalization nor vitamin C treatment alone was able to normalize endothelial dysfunction or oxidative stress. Combining insulin and vitamin C, however, normalized endothelial dysfunction and nitrotyrosine.
CONCLUSIONS: This study suggests that long-lasting hyperglycemia in type 1 diabetic patients induces long-term alterations in endothelial cells, which may contribute to endothelial dysfunction and is interrupted only by both glucose and oxidative stress normalization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491221     DOI: 10.1210/jc.2009-0762

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 2.  Epigenetic phenomena linked to diabetic complications.

Authors:  Luciano Pirola; Aneta Balcerczyk; Jun Okabe; Assam El-Osta
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

3.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

4.  Remodeling is at the heart of chromatin: the heartaches of chromatin.

Authors:  Assam El-Osta
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

Review 5.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Authors:  Marcello C Bertoluci; Gislaine V Cé; Antônio Mv da Silva; Marco V Wainstein; Winston Boff; Marcia Puñales
Journal:  World J Diabetes       Date:  2015-06-10

Review 6.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

7.  PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.

Authors:  Sergey Lupachyk; Hanna Shevalye; Yury Maksimchyk; Viktor R Drel; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2011-02-24       Impact factor: 7.376

8.  VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress.

Authors:  Travis W Hein; Robert H Rosa; Yi Ren; Wenjuan Xu; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

9.  Ascorbic acid blocks hyperglycemic impairment of endothelial function in adolescents with type 1 diabetes.

Authors:  Robert P Hoffman; Amanda S Dye; John A Bauer
Journal:  Pediatr Diabetes       Date:  2012-08-28       Impact factor: 4.866

Review 10.  Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond.

Authors:  Michelle Katz; Elisa Giani; Lori Laffel
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.